VEGFA and neoplasm: VEGF and its receptor 2 (VEGFR2)-mediated angiogenic signaling is the most extensively studied pathway in GAC because high levels of circulating and intratumoral VEGF are correlated with tumor aggressiveness and poor survival (17–19).